Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 13/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.53 |
| ▸ | AR | P10275 | 4/20 | 0.53 |
| ▸ | KLF10 | Q13118 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607257 | 1.00 | ESR1 (0.83) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL1416326 | 0.93 | ESR1 (0.71) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL10935934 | 0.93 | ESR1 (0.71) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL3913903 | 0.91 | ESR1 (0.91) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL29350788 | 0.91 | ESR1 (1.00) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL29360146 | 0.91 | ESR1 (1.00) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL35285 | 0.91 | ESR1 (1.00) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL29696084 | 0.89 | ESR1 (0.95) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL298974 | 0.89 | ESR1 (0.95) | ESR1ALOX15ALOX12ESR2AR | |
| SCHEMBL30606308 | 0.89 | ESR1 (0.66) | ESR1ALOX15ALOX12ESR2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12215189-B2 | Bisphenol composition and polycarbonate resin | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-02-04 | — | — | US | claimed |
| CN-113574042-B | Bisphenol composition and polycarbonate resin | 三菱化学株式会社 | 2023-10-13 | — | — | CN | claimed |
| EP-3939957-A1 | BISPHENOL COMPOSITION AND POLYCARBONATE RESIN | Mitsubishi Chemical Corporation (JP) | 2022-01-19 | — | — | EP | claimed |
| US-20210403641-A1 | BISPHENOL COMPOSITION AND POLYCARBONATE RESIN | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-12-30 | — | — | US | claimed |
| CN-113574042-A | Bisphenol composition and polycarbonate resin | 三菱化学株式会社 | 2021-10-29 | — | — | CN | claimed |
| WO-2020184183-A1 | BISPHENOL COMPOSITION AND POLYCARBONATE RESIN | 三菱ケミカル株式会社 | 2020-09-17 | — | — | WO | claimed |
| EP-1660560-B1 | PHASE TRANSFER CATALYZED METHOD FOR PREPARATION OF POLYETEHRIMIDES | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2016-03-23 | — | — | EP | claimed |
| CN-103497334-A | Copolyetherimides | SABIC INNOVATIVE PLASTICS IP | 2014-01-08 | — | — | CN | claimed |
| CN-1938379-B | Impact-modified compositions and methods | GEN ELECTRIC | 2012-05-16 | — | — | CN | claimed |
| JP-4768635-B2 | — | — | 2011-09-07 | — | — | JP | claimed |
| WO-2005021477-A2 | METHOD FOR MAKING SALTS OF HYDROXY-SUBSTITUTED HYDROCARBONS | GENERAL ELECTRIC COMPANY (US) | 2005-03-10 | — | — | WO | claimed |
| US-20050049390-A1 | Phase transfer catalyzed method for preparation of polyetherimides | GENERAL ELECTRIC COMPANY | 2005-03-03 | — | — | US | claimed |
| US-20050049439-A1 | Method for making salts hydroxy-substituted hydrocarbons | GENERAL ELECTRIC COMPANY | 2005-03-03 | — | — | US | claimed |
| US-6849706-B1 | Copolyetherimides | GENERAL ELECTRIC COMPANY (US) | 2005-02-01 | — | — | US | claimed |
| US-6844071-B1 | Multilayer articles comprising polycarbonate and polypropylene and method for their preparation | GENERAL ELECTRIC COMPANY (US) | 2005-01-18 | — | — | US | claimed |
| US-6713598-B2 | FLAME RETARDANT WITH SPECIFIED MOLECULAR WEIGHT AND SOFTENING TEMPERATURE; REACTING PHOSPHORUS OXYHALIDE WITH HYDROXYAROMATIC COMPOUND, REACTING ARYLDIHALOPHOSPHATE WITH DIHYDROXYAROMATIC, THEN WITH HYDROXYAROMATIC | GENERAL ELECTRIC COMPANY | 2004-03-30 | — | — | US | claimed |
| US-20040044134-A1 | METHOD TO MAKE A SOLID POLYMERIC PHOSPHATE AND RESINOUS COMPOSITIONS CONTAINING IT | GENERAL ELECTRIC COMPANY | 2004-03-04 | — | — | US | claimed |
| WO-2004016685-A2 | FLAME RETARDANT RESINOUS COMPOSITIONS AND METHOD | GENERAL ELECTRIC COMPANY (US) | 2004-02-26 | — | — | WO | claimed |
| US-20040034132-A1 | Flame retardant resinous compositions and method | GENERAL ELECTRIC COMPANY | 2004-02-19 | — | — | US | claimed |
| US-20040014934-A1 | Method for the production of polyestercarbonates | GENERAL ELECTRIC COMPANY | 2004-01-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215189-B2 | Bisphenol composition and polycarbonate resin | SUZ12, RB1, RRP12 | ESR1 71/4885ALOX15 1593/4885ALOX12 467/4885 |
| US-20050049439-A1 | Method for making salts hydroxy-substituted hydrocarbons | HDHD5, SHH, HAAO | ESR1 2614/4885ALOX15 496/4885ALOX12 676/4885 |
| US-20210403641-A1 | BISPHENOL COMPOSITION AND POLYCARBONATE RESIN | SUZ12, RB1, RRP12 | ESR1 71/4885ALOX15 1593/4885ALOX12 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.